Automatic Website Traffic RSS

Merck snaps up cancer drug from China's Kelun in $1.4bn deal

Merck & Co has quietly added another drug to its immuno-oncology pipeline ... alone in previously-untreated non-small cell lung cancer (NSCLC) patients. On Merck's recent first-quarter results ... read more

Better Growth Play: Merck or The Vanguard Growth Index Fund?

According to Wall Street's consensus estimate, Merck's earnings are expected to grow by 14% in 2025, primarily driven by its blockbuster cancer drug, Keytruda. However, it's crucial to note that ... read more

Merck’s stock rallies toward a record after FDA OKs arterial-hypertension drug

Shares of Merck & Co. Inc. rallied into record territory Wednesday, after the drug giant’s treatment for pulmonary arterial hypertension, Winrevair, was approved by the U.S. Food and Drug ... read more

The Next Generation of Cancer Drugs Will Be Made in Space

Immunotherapy is one of the most promising new ways to fight ... benefit that microgravity can give to life science research, drug development, cancer research—and more that we just don't ... read more

Scientists recommend new imaging technique to support design of innovative cancer drugs

Researchers from the Institute of Cancer Research (ICR), Imperial ... “We hope that our work will enable scientists in other labs and institutions or in industry to apply this methodology to drug ... read more

Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug

Merck MRK announced that a phase II/III study has been initiated on its CDH6-directed DXd antibody-drug conjugate ... showed promising activity in patients with advanced ovarian cancer. read more